NORTHERN TRUST CORP - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 131 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$281,000
-94.6%
2,468,275
-19.6%
0.00%
-100.0%
Q3 2018$5,220,000
+2.0%
3,070,949
+4.4%
0.00%0.0%
Q2 2018$5,119,000
-4.6%
2,941,730
+0.3%
0.00%0.0%
Q1 2018$5,368,000
-17.4%
2,933,019
+0.6%
0.00%
-50.0%
Q4 2017$6,498,000
-18.7%
2,914,084
+5.7%
0.00%0.0%
Q3 2017$7,994,000
-36.0%
2,756,445
-1.7%
0.00%
-33.3%
Q2 2017$12,481,000
+10.1%
2,804,768
+15.3%
0.00%0.0%
Q1 2017$11,334,000
-11.0%
2,432,085
+16.3%
0.00%
-25.0%
Q4 2016$12,733,000
+15.3%
2,090,773
+4.3%
0.00%
+33.3%
Q3 2016$11,043,000
+44.4%
2,004,296
-0.4%
0.00%
+50.0%
Q2 2016$7,645,000
+149.3%
2,011,756
+81.0%
0.00%
+100.0%
Q1 2016$3,067,000
-51.7%
1,111,324
-0.7%
0.00%
-50.0%
Q4 2015$6,345,000
+12.2%
1,118,988
+4.8%
0.00%0.0%
Q3 2015$5,657,000
-34.3%
1,067,534
+2.9%
0.00%
-33.3%
Q2 2015$8,612,000
+86.6%
1,037,490
+3.8%
0.00%
+200.0%
Q1 2015$4,616,000
+51.3%
999,056
-0.1%
0.00%0.0%
Q4 2014$3,050,000
+5.1%
1,000,157
-4.1%
0.00%0.0%
Q3 2014$2,903,000
-23.4%
1,042,407
+11.9%
0.00%0.0%
Q2 2014$3,791,000
-30.3%
931,510
-9.0%
0.00%
-50.0%
Q1 2014$5,437,000
-13.9%
1,023,922
-8.7%
0.00%0.0%
Q4 2013$6,313,000
+26.2%
1,121,362
+2.4%
0.00%0.0%
Q3 2013$5,004,000
+40.3%
1,095,163
+32.6%
0.00%
+100.0%
Q2 2013$3,566,000825,6380.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q2 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,009,984$16,683,0006.50%
DAFNA Capital Management LLC 317,563$2,636,0002.23%
Trellus Management Company, LLC 162,900$1,352,0001.53%
PURA VIDA INVESTMENTS, LLC 246,250$2,246,0001.15%
WALL STREET ASSOCIATES 861,200$7,148,0000.67%
EAM Investors, LLC 670,346$5,564,0000.65%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 200,000$1,660,0000.58%
CARL DOMINO INC 66,900$555,0000.38%
Belmont Global Advisors, Inc. 36,200$300,0000.33%
Lombard Odier Asset Management (USA) Corp 507,223$4,210,0000.30%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders